Sanofi Gets $37.6 Million US Gov’t Contract to Supply Radiation Drug Therapy
By

By
Sanofi Genzyme, the specialty care global business unit of Sanofi, has received a $37.6 million contract from the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the…

Janssen to Sell Injectable Pain Meds to Piramal Enterprises
By

By
Janssen Pharmaceutica, a Johnson & Johnson company based in Beerse, Belgium, has agreed to sell five of its anesthesia and pain management injectable products to Critical Care, a UK-based wholly…

Teva, Celltrion Form Biosimilars Partnership
By

By
Teva Pharmaceutical Industries has formed an exclusive partnership with Celltrion, an Incheon, Korea-based life sciences company, and Celltrion Healthcare to commercialize two of Celltrion’s monoclonal antibody (mAb) biosimilar candidates in…

AstraZeneca Divests Nasal Spray Rights to J&J in $330 Million Deal
By

By
AstraZeneca has agreed to divest the rights outside the US of its Rhinocort Aqua (budesonide) nasal spray for allergic and non-allergic rhinitis to Cilag GmbH International, an affiliate of Johnson…

Mylan Agrees to $465 Million EpiPen Settlement with US Gov’t
By

By
Mylan has agreed to a $465 million settlement with the US Department of Justice and other government agencies to resolve questions about whether EpiPen Auto-Injector was properly classified for the…

Takeda, Crescendo Biologics in Therapeutics Pact Worth Up to $790 Million
By

By
Takeda Pharmaceutical Company has formed a collaboration with Crescendo Biologics Limited, a Cambridge, UK-based biopharmaceutical company, to discover, develop, and commercialize Humabody-based cancer therapeutics in a deal worth up to…

Astellas Files Patent-Infringement Suit Against Actavis
By

By
Astellas Pharma and its subsidiaries have jointly filed a lawsuit against Actavis Elizabeth LLC and its affiliates, who have filed an abbreviated new drug application (ANDA) with the US Food…

Pfizer to Sell Hospira Infusion Systems Business for $1 Billion to ICU Medical
By

By
Pfizer has agreed to sell its Hospira Infusion Systems business for $1 billion in cash and stock to ICU Medical, a San Clemente, California-based medical devices company. The Hospira Infusion…

Selexis, IAVI Expand HIV Vaccine Pact
By

By
Selexis, a Geneva, Switzerland-based life sciences company focused on mammalian cell-line generation, has expanded its collaboration with the International AIDS Vaccine Initiative (IAVI) to include two additional service agreements, making…

AbbVie, Mylan Lead News in Drug Approvals
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from AbbVie and Mylan Editor’s Note: This article is updated on a continuous basis for news announced…